380075158 | PUO | 43908087 | | 5038760 | 3/23/2003 12:00:00 AM | Renal failure | | DIS | Admission Date: 10/13/2003 Report Status: Discharge Date: 1/18/2003 ****** DISCHARGE ORDERS ****** TOMA , AYAKO 113-98-54-8 Montana Service: RNM DISCHARGE PATIENT ON: 1/1/03 AT 04:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: ARGANBRIGHT , DENAE DENEEN , M.D. , PH.D. CODE STATUS: Full code DISPOSITION: Home DISCHARGE MEDICATIONS: PHOSLO ( CALCIUM ACETATE ) 1 , 334 MG PO TID Instructions: with meals CATAPRES ( CLONIDINE HCL ) 0.3 MG/DAY TP Q168H HOLD IF: sbp&lt;100 ERYTHROPOIETIN ( EPOETIN ALFA ) 4 , 000 UNITS SC 3x/week LABETALOL HCL 600 MG PO QID HOLD IF: sbp&lt;100 , hr&lt;50 Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
LISINOPRIL 40 MG PO QD HOLD IF: sbp&lt;100 Override Notice: Override added on 1/17/03 by TIBOLLA , MADISON , M.D. on order for POTASSIUM CHLORIDE IV ( ref # 62064556 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: will monitor Previous override information: Override added on 1/17/03 by TIBOLLA , MADISON , M.D. on order for POTASSIUM CHLORIDE IMMED. 
REL. 
PO ( ref # 24585359 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: will monitor PREDNISONE 10 MG PO QOD ZOCOR ( SIMVASTATIN ) 10 MG PO QHS Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
Override Notice: Override added on 7/4/03 by TIBOLLA , MADISON , M.D. on order for NEPHROCAPS PO ( ref # 61290473 ) POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; NIACIN , VIT. B-3 Reason for override: will monitor FK506 ( TACROLIMUS ) 1 MG PO Q12H X 60 Days Food/Drug Interaction Instruction Separate antacids by at least two hours and avoid grapefruit juice NEPHROCAPS ( NEPHRO-VIT RX ) 1 TAB PO QD Alert overridden: Override added on 7/4/03 by TIBOLLA , MADISON , M.D. POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; NIACIN , VIT. B-3 Reason for override: will monitor NIFEDIPINE ( SUSTAINED RELEASE ) ( NIFEDIPINE ( S... ) 30 MG PO QD Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
DOXERCALCIFEROL 2.5 MCG PO QD RENAGEL 800 MG PO TID Instructions: please give only with meals. 
thanks. 
KEFLEX ( CEPHALEXIN ) 500 MG PO QD X 7 Days FLEXERIL ( CYCLOBENZAPRINE HCL ) 10 MG PO TID PRN back pain COLCHICINE 0.6 MG PO QOD DIET: House / ADA 1800 cals/day / Renal diet (FDI) ACTIVITY: Resume regular exercise FOLLOW UP APPOINTMENT( S ): Kidney Doctor - Dr. Pilling , February at 8:40 am 4/4/03 scheduled , Dialysis at Kernan To Dautedi University Of Of Thurs 10/28 at 11:30 am , No Known Allergies ADMIT DIAGNOSIS: end stage renal disease PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) Renal failure OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay dm ( diabetes mellitus ) htn ( hypertension ) sleep apnea ( sleep apnea ) gout ( gout ) depression ( depression ) obesity ( obesity ) left total hip replacement OPERATIONS AND PROCEDURES: None OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) None BRIEF RESUME OF HOSPITAL COURSE: PATIENT IDENTIFICATION: 50 yo male s/p renal transplant presents will acute on chronic renal failure. 
HISTORY OF PRESENT ILLNESS: 50 yo male with ESRD secondary to HTN , on hemodialysis from 94-99 , s/p cadaveric renal transplant in 5/22 Over the past few yrs , pt with increasing Cr: 4 in 2001 , 7 in 2002 , 8 in early February of this year. 
He was in his USOH until 1 wk ago when he developed R axilla infection ( hidradenitis suppurativa ) + DOE. 
Seen in urgent care 10/18 , given keflex. 
Seen in renal clinic 1/27 and labs revealed: Cr of 10 , bicarb 6 , k 6.8. 
Pt then sent to ED. HOSPITAL COURSE: RENAL: Pt admitted with acute on chronic failure. 
The etiology was unclear. 
His FK level was 4.8 , his UA was normal , urine eos were negative. 
His low bicarb was due to his underlying renal failure , and his non-complaince with taking his bicarb replacement at home. 
He was started on D5W + 3 amps HCO3 and was ultimately taken to dialysis 6/11 due to his bicarb. 
As per renal his immunosupressive regimen was changed. 
His cellcept was discontinued , his prednisone was decreased to 10 qod , and his FK dose was decreased from 2 to 1mg bid , and was then to end after a period of 60 days. 
The patients K was initially at 6.8. 
It subsequently decreased with kayexalate and dialysis. 
The patient iPTH was checked and elevated at 399. 
He was to continue dialysis upopn discharge. 
ID - The patient was on renally dosed ancef for a right axilla skin infection which improved during his hospitalization. 
His blood cultures were negative to date at the time of discharge. 
His is to finish a 7 day course of keflex as an outpatient. 
The patient complained of right ankle pain on 8/2 , a plain film revealed no fracture. 
PULM: The patient had an incidental finding of a pulmonary nodule on his CXR. 
A CT revealed that this was just his first right costo-chondrojunction with osteophytes. 
ADDITIONAL COMMENTS: Return to the emergency room or call your doctor for any concern. 
Follow up with your kidney doctor Dr. Pilling Follow up with your primary care doctor for the infection in your arm. 
DISCHARGE CONDITION: Stable TO DO/PLAN: No dictated summary ENTERED BY: TIBOLLA , MADISON , M.D. ( RF05 ) 1/1/03 @ 12 ****** END OF DISCHARGE ORDERS ******